Top

Published in:

29-01-2024 | Prostate Cancer | Interesting image

Discordant Molecular Imaging Findings with 2-[¹⁸F]FDG and [⁶⁸Ga]Ga-PSMA PET/CT in a Patient with Both Bladder and Prostate Cancer

Authors: Aparna Mahalik, Jasim Jaleel, Sambit Sagar, Dikhra Khan, Shobhana Raju, Rakesh Kumar

Published in: Nuclear Medicine and Molecular Imaging | Issue 3/2024

Abstract

The prevalence of double primary prostate and bladder cancer is not uncommon. Though both share a common pathway of malignant transformation, they bear to differ in the case of 2-[¹⁸F]FDG PET/CT and [⁶⁸Ga]Ga-PSMA uptake. We present a case of double primary cancer involving the bladder and prostate, where the prostatic primary showed intense [⁶⁸Ga]Ga-PSMA uptake with non-avid skeletal and pulmonary metastases, which showed intense 2-[¹⁸F]FDG uptake, thus showing discordance due to different clonal origins.

Chun TY. Coincidence of bladder and prostate cancer. J Urol. 1997;157:65–7.CrossRefPubMed

Marselos M, Vainio H. Carcinogenic properties of pharmaceutical agents evaluated in the IARC monographs programme. Carcinogenesis. 1991;12:1751–66.CrossRefPubMed

Mahadevia PS, Koss LG, Tar IJ. Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens. Cancer. 1986;58:2096–102.

Kinoshita Y, Singh A, Rovito PM, Wang CY, Haas GP. Double primary cancers of the prostate and bladder: a literature review. Clin Prostate Cancer. 2004;3:83–6.CrossRefPubMed

Singh A, Jones RF, Friedman H, Hathir S, Soos G, Zabo A, et al. Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. Anticancer Res. 1999;19:5415–7.PubMed

Amara N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F, et al. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res. 2001;61:4660–5.PubMed

Jadvar H. Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations. Eur J Nucl Med Mol Imaging. 2013;40:5–10.CrossRefPubMedCentral

Bakht MK, Lovnicki JM, Tubman J, Stringer KF, Chiaramonte J, Reynolds MR, et al. Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for 18F-FDG imaging of PSMA-suppressed tumors. J Nucl Med. 2020;61:904–10.CrossRefPubMedPubMedCentral

Title: Discordant Molecular Imaging Findings with 2-[18F]FDG and [68Ga]Ga-PSMA PET/CT in a Patient with Both Bladder and Prostate Cancer
Authors: Aparna Mahalik
Jasim Jaleel
Sambit Sagar
Dikhra Khan
Shobhana Raju
Rakesh Kumar
Publication date: 29-01-2024
Publisher: Springer Nature Singapore
Keywords: Prostate Cancer
Prostate Cancer
Metastasis
Molecular Imaging
Published in: Nuclear Medicine and Molecular Imaging / Issue 3/2024
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI: https://doi.org/10.1007/s13139-024-00839-4

At a glance: The STEP trials

Springer Medicine

Discordant Molecular Imaging Findings with 2-[¹⁸F]FDG and [⁶⁸Ga]Ga-PSMA PET/CT in a Patient with Both Bladder and Prostate Cancer

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2024

Recent Updates on Applications of Artificial Intelligence for Nuclear Medicine Professionals: Prostate Cancer and PET/CT

Annotating the Role of 18F-FDG PET/CT in Fibromatoses: A Benign Masquerader of Malignancies—Is It Really an Advantageous Tool?

Incidentally Detected Gallbladder Carcinoma: Can F-18 FDG PET/CT Aid in Staging and Prognostication?

Contribution of ChatGPT in Parkinson’s Disease Detection

Uncertainty Analysis of Time-Integrated Activity Coefficient in Single-Time-Point Dosimetry Using Bayesian Fitting Method

Hepatic Superscan in Medullary Thyroid Carcinoma: A Rare Presentation in [18F]FDG PET/CT